Compare NSPR & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSPR | UCL |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7M | 38.1M |
| IPO Year | 2009 | 2019 |
| Metric | NSPR | UCL |
|---|---|---|
| Price | $0.72 | $0.91 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 85.7K | 7.1K |
| Earning Date | 05-04-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,310,000.00 | N/A |
| Revenue This Year | $57.98 | $11.60 |
| Revenue Next Year | $95.41 | N/A |
| P/E Ratio | ★ N/A | $13.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.63 | $0.88 |
| 52 Week High | $2.93 | $4.19 |
| Indicator | NSPR | UCL |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 44.05 |
| Support Level | $0.69 | $0.88 |
| Resistance Level | $1.04 | $0.97 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 71.29 | 36.71 |
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data-related products globally. Its uCloudlink cloud SIM platform is designed for shared mobile data connectivity services by allocating the SIM cards remotely and dynamically to users. Ucloudlink's core business is to provide mobile data connectivity services at competitive prices, which it delivers through a range of hardware products and service solutions to its business partners, retail, and enterprise customers. The main hardware terminals offered by the company include portable Wi-Fi terminals, smartphones, and smart-hardware products for international and local mobile data connectivity services. Geographically, it generates maximum revenue from Japan.